SkinHealth Systems Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| EXHIBIT INDEX | ||||||
|---|---|---|---|---|---|---|
| No. | Description of Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 2.1 | Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc., Hydrate Merger Sub II, LLC, LCP Edge Intermediate, Inc. and LCP Edge Holdco, LLC, in its capacity as the Stockholders’ Representative | 8-K | 001-39565 | 2.1 | December 9, 2020 | |
| 3.1 | Third Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation | 8-K | 001-39565 | 3.1 | April 22, 2026 | |
| 3.2 | Restated Certificate of Incorporation of SkinHealth Systems Inc. | 8-K | 001-39565 | 3.2 | April 22, 2026 | |
| 3.3 | Second Amended and Restated Bylaws of SkinHealth Systems Inc. | 8-K | 001-39565 | 3.3 | April 22, 2026 | |
| 4.1 | Indenture, dated as of September 14, 2021, between The Beauty Health Company and U.S. Bank National Association, as trustee | 8-K | 001-39565 | 4.1 | September 14, 2021 | |
| 4.2 | Form of certificate representing the 1.25% Convertible Senior Notes due 2026 (included as Exhibit A to Exhibit 4.1) | 8-K | 001-39565 | 4.2 | September 14, 2021 | |
| 4.3 | Warrant Agreement, dated September 29, 2020, between the Company and Continental Stock Transfer & Trust Company, as warrant agent | 8-K | 001-39565 | 4.1 | October 5, 2020 | |
| 4.4 | Indenture, dated May 27, 2025, between The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent | 10-Q | 001-39565 | 4.4 | August 7, 2025 | |
| 4.5 | Form of Note representing the 7.95% Convertible Senior Secured Notes due 2028 (included as Exhibit A to Exhibit 4.4) | 10-Q | 001-39565 | 4.5 | August 7, 2025 | |
| 4.6 | Supplemental Indenture No. 1, dated September 4, 2025, among The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent | 8-K | 001-39565 | 4.1 | September 4, 2025 | |
| 4.7 | Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 | 10-K | 001-39565 | 4.7 | March 12, 2026 | |
| 10.1 | Severance and General Release Agreement, entered into May 15, 2026, by and among Hydrafacial LLC, SkinHealth Systems Inc., and Ronald Menezes | 8-K/A | 001-39565 | 10.1 | May 21, 2026 | |
| 31.1 | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| EXHIBIT INDEX | ||||||
|---|---|---|---|---|---|---|
| No. | Description of Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 101.INS** | Inline XBRL Instance Document | X | ||||
| 101.SCH** | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL** | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.DEF** | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||
| 101.LAB** | Inline XBRL Taxonomy Extension Labels Linkbase Document | X | ||||
| 101.PRE** | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 104** | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 attachments) | |||||
- These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
** The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
† Confidential portions of this exhibit were redacted pursuant to Item 601(b)(10) of Regulation S-K, and the Company agrees to furnish to the SEC a copy of any omitted schedule and/or exhibit upon request.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.